Cell and Gene Therapy, Cell Therapy, Leadership
May 05, 2025
Cell and Gene Therapy, Cell Therapy, cGMP Manufacturing, Tech Transfer
March 11, 2025
RoslinCT and Ayrmid Pharma Ltd. Announce Their Intent to Enter Into a Strategic Partnership to Manufacture FDA Approved Cell Therapy Omisirge® (omidubicel-onlv)
![[WEBINAR] Building the Future of Cell based Therapy Trends, Technologies, and Transformations](https://www.roslinct.com/wp-content/uploads/2025/02/Screenshot-2025-02-11-085812-410x231.png)
Cell and Gene Therapy, Cell Therapy
February 11, 2025
[WEBINAR] Building the Future of Cell based Therapy Trends, Technologies, and Transformations
Cell Therapy, Leadership
November 04, 2024
RoslinCT Announces Appointment of Jessica Carmen as Chief Commercial Officer
Cell and Gene Therapy, Cell Therapy
September 30, 2024
RoslinCT Wins Manufacturer of the Year at the 9th Massachusetts Manufacturing Awards Ceremony
Cell and Gene Therapy, Cell Therapy, Leadership
June 25, 2024
RoslinCT Appoints Professor Sir Peter Mathieson and Alexander Vos as New Non-Executive Directors
Cell and Gene Therapy, Cell Therapy, cGMP Manufacturing
December 11, 2023
RoslinCT to manufacture first-ever US FDA approved CRISPR-based gene therapy CASGEVY™ (exagamglogene autotemcel)
Cell and Gene Therapy, Cell Therapy, cGMP Manufacturing
November 28, 2023
RoslinCT to manufacture exagamglogene autotemcel (exa-cel) for Vertex Pharmaceuticals Inc following an extensive development collaboration
Cell Therapy, cGMP Manufacturing
June 05, 2023